Kubota Pharmaceutical Holdings Co Ltd (4596) Stock Price & News

Why is 4596 down 5.45%?

Dive Deeper

4596:TYO

Kubota Pharmaceutical Holdings Co Ltd

¥52.00

-5.45%

(-3.00) 1D

Nov 6, 3:30:00 PM GMT+9 · JPY

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 4596...

Open

¥53

High

¥54

Low

¥51

Mkt. cap

8.43B

Avg. vol.

473.51K

Volume

1.35M

52-wk high

¥350

52-wk low

¥41

EPS

-¥8

Shares outstanding

40.24M

No. of employees

Open

¥53

High

¥54

Low

¥51

Mkt. cap

8.43B

Avg. vol.

473.51K

Volume

1.35M

52-wk high

¥350

52-wk low

¥41

EPS

-¥8

Shares outstanding

40.24M

No. of employees

Related stocks

BrightPath Biotherapeutics Co Ltd

Oncolys Biopharma Inc

¥7,400.00

-1.99%

News stories

From web sources and news partners

BigGo Finance

39 minutes ago

Five S&P Names Put Big Buyback Money to Work as Nasdaq Slips Into Correction

Investing.com

27 minutes ago

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.26%

ChartMill

58 minutes ago

S&P 500 Top Movers: Nov. 6, 2026 Gainers and Losers

Yahoo Finance

1 hour ago

After the Midterm Rally, the Dow Is on Track to Beat the Nasdaq for the First Time Since 2022. Here's What History Says Could Come Next.

About Kubota Pharmaceutical Holdings Co Ltd

CEO-

Employees8

FoundedDec 11, 2015

HeadquartersSeattle, Washington, United States

SectorHealth Care

IndustryPharmaceutical industry

Websitekubotaholdings.co.jp

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	5.46M	2.76M	4.69M	2.31M
Cost of goods sold	1.30M	20.09M	1.52M	20.48M
Cost of revenue	1.30M	20.09M	1.52M	20.48M
Research and development expenses	96.68M	69.74M	139.33M	173.67M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	107.34M	152.91M	166.09M	143.91M
Operating expense	208.08M	186.70M	316.44M	318.56M
Total operating expenses	209.38M	206.79M	317.96M	339.04M
Operating income	-203.92M	-204.02M	-313.26M	-336.74M
Other non operating income	-172.00K	217.21M	-248.00K	248.00K
EBT including unusual items	14.61M	-240.80M	-312.13M	-336.87M
EBT excluding unusual items	-203.26M	13.07M	-312.13M	-336.87M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	4.07M	-35.96M	11.02M	983.00K
Net income	14.61M	-240.80M	-312.13M	-336.87M
Net profit margin	267.68%	-8,708.86%	-6,649.47%	-14,608.59%
Earnings per share	-	-	-	-
Interest and investment income	975.00K	739.00K	1.51M	121.00K
Interest expense	-140.00K	-851.00K	-121.00K	-508.00K
Net interest expenses	835.00K	-112.00K	1.39M	-387.00K
Depreciation and amortization charges	-	-	-	-
EBITDA	-187.51M	-187.77M	-	-
Gain or loss from assets sale	-	36.00M	-	12.00M

Ask anything